EuropaBio Response to EC Consultation on Concept Paper on Clinical Trial Directive Revision

26.05.2011
EuropaBio Response to EC Consultation on Concept Paper on Clinical Trial Directive Revision 2001/20/EC

EuropaBio welcomes the opportunity to submit these comments which represent the views of our members in response to the questions posed in the concept paper on the revision of the Clinical Trials Directive 2001/20/EC. We also offer recommendations to ensure a supportive regulatory environment for conducting clinical trials in the European Community.

EuropaBio looks forward to continuing to work with the European Commission and other stakeholders in the development of the legislative proposal for the revision of the Clinical Trials Directive to the ultimate benefit of both patients and the bioscience industry. We believe it is important to improve the competitivenessof the EU as a location for clinical research and the development of new, innovative medicines.
 

Latest Position papers